Compound Detail
CHEMBL3329652
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL3329652 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | LBAGNMNWIAWTLK-WQRHYEAKSA-N |
6
Targets
6
Activities
1
Assay Types
0
PK Parameters
12
Publications
0
Known Names
Molecular Properties
402.4
MW (Da)
3.48
ALogP
4
HBA
4
HBD
112.3
PSA (Ų)
0.50
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 6 meas. best 7.83
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Aurora kinase B CHEMBL2185 | IC50 | 7.83 | 7.83 | 14.9 | 1 |
| MOLM-13 CHEMBL3706572 | IC50 | 7.74 | 7.74 | 18.1 | 1 |
| NON-PROTEIN TARGET CHEMBL3879801 | IC50 | 7.53 | 7.53 | 29.5 | 1 |
| MV4-11 CHEMBL613835 | IC50 | 7.53 | 7.53 | 29.3 | 1 |
| THP-1 CHEMBL614245 | IC50 | 7.17 | 7.17 | 68.4 | 1 |
| Receptor-type tyrosine-protein kinase FLT3 CHEMBL1974 | IC50 | 6.48 | 6.48 | 333.9 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Aurora kinase B | IC50 | = | 14.9 | nM | 7.83 | Inhibition of Aurora B (unknown origin) using HLRRASLG substrate | 25089810 |
| MOLM-13 | IC50 | = | 18.1 | nM | 7.74 | Cytotoxicity against human MOLM13 cells assessed as cell viability after 48 hrs ... | 25089810 |
| MV4-11 | IC50 | = | 29.3 | nM | 7.53 | Cytotoxicity against human MV4-11 cells assessed as cell viability after 48 hrs ... | 25089810 |
| NON-PROTEIN TARGET | IC50 | = | 29.5 | nM | 7.53 | Cytotoxicity against human HL60 cells assessed as cell viability after 48 hrs by... | 25089810 |
| THP-1 | IC50 | = | 68.4 | nM | 7.17 | Cytotoxicity against human THP1 cells assessed as cell viability after 48 hrs by... | 25089810 |
| Receptor-type tyrosine-protein kinase FLT3 | IC50 | = | 333.9 | nM | 6.48 | Inhibition of FLT3 (unknown origin) using EAIYAAPFAKKK substrate | 25089810 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 25089810 | 10.1016/j.ejmech.2014.07.108 | Aurora kinase B | 2 |
| 25089810 | 10.1016/j.ejmech.2014.07.108 | Receptor-type tyrosine-protein kinase FLT3 | 1 |
| 25089810 | 10.1016/j.ejmech.2014.07.108 | MV4-11 | 1 |
| 25089810 | 10.1016/j.ejmech.2014.07.108 | MOLM-13 | 1 |
| 25089810 | 10.1016/j.ejmech.2014.07.108 | THP-1 | 1 |
| 25089810 | 10.1016/j.ejmech.2014.07.108 | NON-PROTEIN TARGET | 1 |
| 25089810 | 10.1016/j.ejmech.2014.07.108 | ADMET | 1 |
| 25089810 | 10.1016/j.ejmech.2014.07.108 | Aurora kinase A | 1 |
| 25089810 | 10.1016/j.ejmech.2014.07.108 | Aurora kinase C | 1 |
| 25089810 | 10.1016/j.ejmech.2014.07.108 | Platelet-derived growth factor receptor alpha | 1 |
| 25089810 | 10.1016/j.ejmech.2014.07.108 | Platelet-derived growth factor receptor beta | 1 |
| 25089810 | 10.1016/j.ejmech.2014.07.108 | Unchecked | 1 |
Data from ChEMBL 36 via Core Engine